Healthcare

Background/Objectives: Athletes face both daily and sport-related stressors while being expected to perform at an optimal level. Effective recovery, particularly adequate sleep, plays a key role in psychophysiological restoration and performance, whereas sleep deprivation may impair functioning and increase perceived stress. This study examined the associations between coping strategies, sleep quality, athletic experience, competitive level, and perceived stress during the pre-competition period among female volleyball players. Methods: Ninety-one athletes (aged 18–35, M = 23.03, SD = 4.37) from three Polish professional leagues—Tauron (n = 31), First League (n = 30), and Second League (n = 30)—completed an online battery including the Stress Coping Strategies in Sport Questionnaire (SR3S), the Perceived Stress Scale (PSS-4), the Pittsburgh Sleep Quality Index (PSQI), and a demographic survey. Results: Based on PSQI scores, approximately 60% of the athletes were classified as poor sleepers. No significant differences in sleep quality or perceived stress were found across leagues. However, athletes competing in higher leagues reported more frequent use of mental coping strategies. Athletic experience, sleep quality, and the coping strategy of seeking social support were significantly associated with perceived stress. Players with less experience, poorer sleep, and a greater tendency to seek social support reported higher stress levels. The positive association between support-seeking and stress likely reflects reactive coping among more stressed athletes rather than a maladaptive effect of social support. Conclusions: These findings underscore the importance of promoting adaptive coping and sleep hygiene in competitive sport, particularly among less experienced female athletes during the pre-competition period.

Background/Objectives: People living with depression often experience consistent disruptions in their experience of time, which further contributes to their suffering. We present a scoping review on virtual reality (VR)-based interventions for depression, addressing temporal processing and subjective experiences of time. The paper aims to explore the extent to which therapeutic interventions using VR target the temporal dimension of patients’ experiences. Methods: We conducted a scoping review using the PRISMA 2020 standard. The literature search was further extended using Research Rabbit and by examining the reference lists of relevant articles. Seventeen papers were selected for final analysis. Results: Our scoping review indicates that temporality in VR-based therapeutic interventions for depression remains underrepresented. Of the seventeen papers reviewed, only two explicitly deal with this issue, while the rest touch upon it briefly or implicitly. The studies suggest that VR’s main advantage in modifying the experience of time in depression is its potential to generate immersion and to scaffold imagination through visualization. The main limitations are methodological: most of the available research is exploratory, reports short-term effects, and utilizes a broad variety of empirical designs and therapeutic approaches.

Background: Sexual dysfunction (SD) affects up to two-thirds of individuals with early-onset Parkinson’s disease (PD), yet it remains underexplored in developing countries where stigma, depression, and treatment side effects may worsen its burden. This study investigated the magnitude and correlation of SD in early-onset PD. Methods: A cross-sectional study included 74 individuals with PD onset at ≤55 years of age. SD was assessed using the Medical Outcomes Study Sexual Functioning Scale, alongside interviews on sexual experiences after initiating PD medication. Prevalence was estimated descriptively, and Spearman’s correlation identified correlates of SD. Results: Half of participants reported SD, including lack of sexual interest (52.7%), difficulty relaxing or enjoying sex (52.7%), and impaired arousal (50%). Among men, 48% experienced erectile problems, while 44% of women reported difficulty achieving orgasm. After starting anti-Parkinson’s medication, 16% noted markedly reduced sexual desire, whereas nearly 10% reported increased desire. In men, SD correlated with levodopa dose (r = 0.411, p < 0.01). In women, SD correlated with stigma (r = 0.389, p < 0.05), depression (r = 0.529, p < 0.01), and anxiety (r = 0.629, p < 0.01). Conclusions: One in two individuals with early-onset PD experiences SD, independent of gender. Findings highlight the need for routine sexual health assessment and careful monitoring of treatment side effects. Interventions targeting stigma, depression, and anxiety are critical to improve sexual well-being in this population.